FLUORO-CONTAINING DERIVATIVES OF HYDROGENATED PYRIDO[4,3-B]INDOLES WITH NEUROPROTECTIVE AND COGNITION ENHANCING PROPERTIES, PROCESS FOR PREPARING, AND USE
First Claim
1. A compound having a general formula:
- wherein the solid line accompanied by the dotted line () represents a single or double bond;
Rf is selected from a fluorine atom, two fluorine atoms, or a trifluoromethyl group;
R1 is selected from a H, (C1-C6) alkyl;
hydroxyl (C2-C6) alkyl;
(hetero) aryl (C2-C6) alkyl;
(C3-C7) cycloalkyl;
(C2-C6) alkenyl;
(C1-C6) alkylsulfonyl;
(hetero) arylsulfonyl;
(C1-C6) alkanoyl;
(hetero)) aroyl, (C1-C6) alkoxycarbonyl;
(C1-C6) alkoxy (C1-C6) alkyl;
(hetero) aryloxy (C1-C6) alkyl;
amino (C1-C6) alkyl, wherein the amino group may be optionally substituted by alkyl, (hetero) aryl, alkenyl, alkanoyl, (hetero) aroyl and other;
or a group CONR8R9 or SO2NR8N9, wherein R8 and R9 independently represent hydrogen or (C1-C6) alkyl, or R8 and R9 together with the nitrogen atom to which they are attached may form a nitrogen-containing heterocyclic or nitrogen-containing heteroaryl group;
R2 and R3 are chosen independently from a hydrogen and a methyl group; and
R4, R5, R6 and R7 each represent, independently of each other, a hydrogen or halogen atom or a trifluoromethyl, trifluoromethoxy, cyano, hydroxyl, (C1-C6) alkyl, (C1-C6) alkoxy, phenoxy, phenyl or pyridyl group optionally substituted with a halogen atom or a methyl, methoxy, cyano, trifluoromethyl, or hydroxyl group.
3 Assignments
0 Petitions
Accused Products
Abstract
Some exemplary embodiments comprise fluoro-containing derivatives of pyrido[4,3-b]indoles (and exemplary methods of making the same) that may be administered to a mammal (including a human) in an effective amount for potential use in the treatment or prophylaxis of neurological disorders including AD, mild cognitive impairment, senile and vascular dementia, HD, ALS, Parkinson'"'"'s disease, AIDS-related dementia, ischaemic cerebral pathologies, neuropathic pain, ADHD (attention deficit disorder/hyperactivity syndrome), eating disorders such as anorexia and bulimia, panic attacks, withdrawal from drug abuse such as cocaine, ethanol, nicotine and benzodiazepines, schizophrenia (in particular the cognitive deficit of schizophrenia), stroke and also disorders associated with spinal trauma and/or head injury. These derivatives may also be useful for the treatment of borderline personality disorder, obesity, and for use as geroprotectors. The compounds may also be used as “pharmacological tools” for an investigation of the mechanism of protection against neurodegeneration disorders in vivo or in vitro.
33 Citations
20 Claims
-
1. A compound having a general formula:
wherein the solid line accompanied by the dotted line () represents a single or double bond; Rf is selected from a fluorine atom, two fluorine atoms, or a trifluoromethyl group; R1 is selected from a H, (C1-C6) alkyl;
hydroxyl (C2-C6) alkyl;
(hetero) aryl (C2-C6) alkyl;
(C3-C7) cycloalkyl;
(C2-C6) alkenyl;
(C1-C6) alkylsulfonyl;
(hetero) arylsulfonyl;
(C1-C6) alkanoyl;
(hetero)) aroyl, (C1-C6) alkoxycarbonyl;
(C1-C6) alkoxy (C1-C6) alkyl;
(hetero) aryloxy (C1-C6) alkyl;
amino (C1-C6) alkyl, wherein the amino group may be optionally substituted by alkyl, (hetero) aryl, alkenyl, alkanoyl, (hetero) aroyl and other;
or a group CONR8R9 or SO2NR8N9, wherein R8 and R9 independently represent hydrogen or (C1-C6) alkyl, or R8 and R9 together with the nitrogen atom to which they are attached may form a nitrogen-containing heterocyclic or nitrogen-containing heteroaryl group;R2 and R3 are chosen independently from a hydrogen and a methyl group; and R4, R5, R6 and R7 each represent, independently of each other, a hydrogen or halogen atom or a trifluoromethyl, trifluoromethoxy, cyano, hydroxyl, (C1-C6) alkyl, (C1-C6) alkoxy, phenoxy, phenyl or pyridyl group optionally substituted with a halogen atom or a methyl, methoxy, cyano, trifluoromethyl, or hydroxyl group. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)
-
19. A compound or a pharmacologically acceptable salt thereof, which is selected from a group consisting of:
-
5-[2-(5-fluoropyridin-3-yl)ethyl]-2-i-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 5-[2-(5-fluoropyridin-3-yl)ethyl]-2,8-dimethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 8-fluoro-5-[2-(5-fluoropyridin-3-yl)ethyl]-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 8-chloro-5-[2-(5-fluoropyridin-3-yl)ethyl]-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 8-bromo-5-[2-(5-fluoropyridin-3-yl)ethyl]-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 5-[2-(5-fluoropyridin-3-yl)ethyl]-8-methoxy-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 5-[2-(5-fluoropyridin-3-yl)ethyl]-2,6,8-trimethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 6,8-difluoro-5-[2-(5-fluoropyridin-3-yl)ethyl]-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 5-[2-(5-fluoropyridin-3-yl)ethyl]-2-methyl-8-(trifluoromethyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 5-[2-(5-fluoropyridin-3-yl)ethyl]-2-methyl-8-(trifluoromethoxy)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 2-ethyl-5-[2-(5-fluoropyridin-3-yl)ethyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 2-ethyl-5-[2-(5-fluoropyridin-3-yl)ethyl]-8-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 2-benzyl-5-[2-(5-fluoropyridin-3-yl)ethyl]-8-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 2-ethyl-8-fluoro-5-[2-(5-fluoropyridin-3-yl)ethyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; and 8-chloro-2-ethyl-5-[2-(5-fluoropyridin-3-yl)ethyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole.
-
-
20. A compound or a pharmacologically acceptable salt thereof, which is selected from a group consisting of:
-
5-[2-(5-fluoropyridin-3-yl)ethyl]-2-iso-propyl-2,3,4,5-tetrahydro-1H pyrido[4,3-b]indole; 5-[2-(5-fluoropyridin-3-yl)ethyl]-2,8-diethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 8-fluoro-5-[2-(5-fluoropyridin-3-yl)ethyl]-2-iso-propyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 8-chloro-5-[2-(5-fluoropyridin-3-yl)ethyl]-2-iso-propyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 8-bromo-5-[2-(5-fluoropyridin-3-yl)ethyl]-2-ethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 5-[2-(5-fluoropyridin-3-yl)ethyl]-8-methoxy-2-ethyl-2,3,4,5-tetrahydro-4H-pyrido[4,3-b]indole; 5-[2-(5-fluoropyridin-3-yl)ethyl]-2-ethyl-6,8-dimethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 6,8-difluoro-5-[2-(5-fluoropyridin-3-yl)ethyl]-2-ethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 5-[2-(5-fluoropyridin-3-yl)ethyl]-2-ethyl-8-(trifluoromethyl)-2,3,4,5-tetrahydro-4H-pyrido[4,3-b]indole; 5-[2-(5-fluoropyridin-3-yl)ethyl]-2-ethyl-8-(trifluoromethoxy)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 2-tret-butyl-5-[2-(5-fluoropyridin-3-yl)ethyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 2-iso-propyl-5-[2-(5-fluoropyridin-3-yl)ethyl]-8-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 2-tret-butyl-5-[2-(5-fluoropyridin-3-yl)ethyl]-8-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 2-tret-butyl-8-fluoro-5-[2-(5-fluoropyridin-3-yl)ethyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 8-chloro-2-tret-butyl-5-[2-(5-fluoropyridin-3-yl)ethyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 5-[2-(5-fluoropyridin-3-yl)ethyl]-2,8-diethyl-6-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 8-ethyl-5-[2-(5-fluoropyridin-3-yl)ethyl]-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 8-ethyl-5-[2-(5-fluoropyridin-3-yl)ethyl]-2,6-dimethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 8-ethyl-5-[2-(5-fluoropyridin-3-yl)ethyl]-2-iso-propyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 8-ethyl-5-[2-(5-fluoropyridin-3-yl)ethyl]-2-iso-propyl-6-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 8-ethyl-5-[2-(5-fluoropyridin-3-yl)ethyl]-2-tret-butyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 8-ethyl-5-[2-(5-fluoropyridin-3-yl)ethyl]-2-tret-butyl-6-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 2-methyl-5-{2-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 2,8-dimethyl-5-{2-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 8-fluoro-2-methyl-5-{2-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 8-chloro-2-methyl-5-{2-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 2-methyl-8-(trifluoromethyl)-5-{2-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 5-[2-(6-fluoropyridin-3-yl)ethyl]-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 5-[2-(6-fluoropyridin-3-yl)ethyl]-2,8-dimethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 8-fluoro-5-[2-(6-fluoropyridin-3-yl)ethyl]-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 5-[2-(2-fluoropyridin-4-yl)ethyl]-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 5-[2-(2-fluoropyridin-4-yl)ethyl]-2,8-dimethyl-2,3,4,5-tetrahydro-4H-pyrido[4,3-b]indole; 8-fluoro-5-[2-(2-fluoropyridin-4-yl)ethyl]-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 5-[2-(3-fluoropyridin-4-yl)ethyl]-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 5-[2-(3-fluoropyridin-4-yl)ethyl]-2,8-dimethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 8-fluoro-5-[2-(3-fluoropyridin-4-yl)ethyl]-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 2-methyl-5-{2-[2-(trifluoromethyl)pyridin-4-yl]ethyl}-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 2,8-dimethyl-5-{2-[2-(trifluoromethyl)pyridin-4-yl]ethyl}-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole; 8-fluoro-2-methyl-5-{2-[2-(trifluoromethyl)pyridin-4-yl]ethyl}-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole;
2-{5-[2-(5-fluoropyridin-3-yl)ethyl]-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indol-2-yl}ethanol;2-{5-[2-(5-fluoropyridin-3-yl)ethyl]-8-methyl-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indol-2-yl}ethanol; and 2-{8-fluoro-5-[2-(5-fluoropyridin-3-yl)ethyl]-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indol-2-yl}ethanol.
-
Specification